EN DE
Watch BML, Inc. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

BML, Inc. (BMLKF) fair value: what the stock is really worth

As of Nov 12, 2026: fair value (intrinsic value) of BML, Inc. stock $33.44, price $24.64, upside +35.7%, quality 70 out of 100. Rating: undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Based in Japan

BI BML, Inc. logo Broad data Nov 14, 2026

BML, Inc.

BMLKF · US

Cheap (26% below fair value) and solid company.

Get notified free when this changes
Fair value $33.44 · Undervalued 
Quality 70/100 
Generates free cash flow 
3.2% dividend yield · Sustainable
Ranks above peers (12/13) 
Broad data 
Even on cautious assumptions the value is 10% above the price ($27.21). 
Thin margins · 5.2% net margin (TTM) 
Changed on Oct 26: $28.81 → $33.44 
Weak Growth (revenue 5y +1.6 %/yr in JPY) 
Narrow moat 36/100
Price via web search⚠ Thinly traded
Watch BML, Inc. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$24.64 $8.81 Fair Value $33.44 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

60‑month range $8.81 – $24.64 · fair‑value band $27.21 – $40.80 · the $24.64 price screens below the $33.44 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.

Follow BML in your weekly email

Every Wednesday you see whether BML is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

BML, Inc. provides contract clinical testing and related services in Japan.

Show moreShow less

The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing.

It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds.

In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services.

The company was incorporated in 1955 and is headquartered in Tokyo, Japan.

Stock analysis

BML, Inc. (BMLKF) currently trades at $24.64, while our model-based Fair Value estimate is $33.44, implying the stock looks roughly 26% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $37.61 per share, and 17 of the 24 models we run sit above the $24.64 price.

Bear case: the Asset-Based group reads lowest at $7.73, and 7 of the 24 models stay below the price. Data coverage for this calculation is high.

Scenario range: $27.21 (bear) to $40.80 (bull), the price of $24.64 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 70/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

BML, Inc. reported revenue of ¥150B in FY2026 versus ¥186B in FY2022, a compound −5.2%/yr. Reported net income was ¥7.7B in FY2026, compounding −30.8%/yr from FY2022.

Key figures

Market cap $923M Small · P/E ratio 18.7 · P/S ratio 0.96 · EPS (TTM) $1.32 · Dividend yield 3.2% · Net margin 5.2% · Return on equity 6.2% · Return on assets (EBIT) 11.6% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 36 out of 100 (medium confidence).

What moves the price

The share trades about 2% below its 52-week high and 25% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at 36%, BMLKF screens cheaper than that median.

Fair Value models

Bear $27.21 Fair Value $33.44 Bull $40.80
Price $24.64 · Upside +35.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then ($0.3384 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $27.96 $33.13 $43.06 80
Growth DCF $28.53 $33.54 $42.34 77
Residual Income $16.71 $17.28 $18.48 76
All 24 models by family
DCF Models
FCF DCF $27.96 $33.13 $43.06 80
Owner Earnings $28.52 $33.86 $44.14 75
5Y Revenue Exit $26.83 $33.35 $43.16 71
5Y EBITDA Exit $35.80 $48.58 $66.04 73
5Y P/E Exit $29.10 $37.21 $47.23 69
10Y Revenue Exit $26.76 $32.25 $38.39 66
10Y EBITDA Exit $32.45 $41.84 $52.45 67
10Y P/E Exit $28.50 $34.68 $40.89 63
Earnings-Based
Graham-Dodd $8.83 $13.97 $16.79 67
EPV $23.59 $25.45 $27.04 68
Dividend Discount
Gordon GGM $10.22 $12.03 $13.98 69
DDM Multi-Stage $10.22 $13.19 $16.75 67
Multiples
P/E Multiple $21.43 $28.57 $35.71 63
P/S Multiple $16.56 $22.08 $27.60 58
P/B Multiple $69.56 $92.75 $115.94 55
EV/EBIT $33.68 $41.10 $48.52 63
EV/EBITDA $45.80 $57.26 $68.73 64
EV/Revenue $27.30 $34.11 $40.92 52
Asset-Based
NCAV (Graham) $5.10 $7.73 $9.66 52
Growth DCF
Growth DCF $28.53 $33.54 $42.34 77
Rev-Margin DCF $26.83 $33.75 $42.54 71
Economic Profit
Residual Income $16.71 $17.28 $18.48 76
ROIC Compounder $23.68 $25.84 $28.18 70
Growth Earnings
Growth-Adj P/E $15.11 $21.58 $28.05 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 70/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 42
How much profit the company makes from its sales and capital
Quality Growth 54
Are margins and returns getting better?
Cashflow 55
Do the profits arrive as real cash?
Financial strength 93
Debt, balance sheet and risk of trouble
Investment 86
Does it invest with discipline instead of growing at any price?
Low Volatility 97
How calm the share price moves, does not count
Price momentum 51
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 82
Distance to the 52-week high, does not count
New shares 98
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+4.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.6%
Start year 2021 (pandemic)
What shareholders gained per year (last 5 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−15.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−19.0%
Dividend (yield on the price)3.2%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.14% → 7%

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−8.1%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about −9.9% a year for the price.

Watch BMLKF, get fair value alerts →

Compare BML, Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 151 stocks

Beats the industry median on 12/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 70 · Top 25%
Fair Value upside +35.7% · Top 25%
Profitability
Return on equity (12 months) 6.2% · Above median
Return on assets 4.2% · Above median
Net margin (12 months) 5.2% · Above median
Operating margin (12 months) 7.7% · Above median
Growth and dividend
Revenue growth (quarter YoY) 2.7% · Below median
Dividend yield (12 months) 3.2% · Above median

Valuation Multiplesvs Diagnostics & Research median · lower = cheaper

P/E (12 months) 18.7× · Cheapest 25%
P/B 1.15× · Cheapest 25%
P/S (12 months) 0.97× · Cheapest 25%
Price / free cash flow (fiscal year) 13.9× · Cheapest 25%
EV/EBITDA 4.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)81 · sector 19
FUTURE (revenue growth)14 · sector 40
PAST (return on equity)25 · sector 9
HEALTH (low debt)0 · sector 95
DIVIDEND (yield)64 · sector 33

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Illumina, Inc ILMN $198.00 $227.71 +15% vs BMLKF
WuXi AppTec Co 603259 ¥144.41 ¥164.66 +14% vs BMLKF
IQVIA Holdings IQV $264.73 $291.63 +10% vs BMLKF
Thermo Fisher Scientific Inc TMO $691.33 $686.04 −1% vs BMLKF
Danaher Corporation DHR $229.91 $209.18 −9% vs BMLKF
IDEXX Laboratories, Inc IDXX $700.65 $496.48 −29% vs BMLKF
Lonza Group LONN CHF 670.20 CHF 259.80 −61% vs BMLKF
Mettler-Toledo International Inc MTD $1,727 $655.06 −62% vs BMLKF
Agilent Technologies, Inc A $172.92 $64.20 −63% vs BMLKF
Waters Corporation WAT $453.42 $91.26 −80% vs BMLKF

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

BML, Inc.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "BML, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/BMLKF

Frequently asked questions

Is BML, Inc. (BMLKF) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of $33.44 versus a price of $24.64, about +36% upside (undervalued).
What is the fair value of BMLKF?
Our model-based fair value for BML, Inc. is $33.44 (as of Nov 14, 2026), built from audited fundamentals. The current price: $24.64.
What is the quality score of BMLKF?
BML, Inc. has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for BML, Inc. (BMLKF)?
Our model-based price target is the fair value of $33.44 (as of Nov 14, 2026) from 24 valuation models. Cautious scenario $27.21, optimistic scenario $40.80. It is a calculation from audited fundamentals, not an analyst target.
What is the BML, Inc. stock forecast for 2026?
Our models put fair value at $33.44, about +36% upside versus a price of $24.64 (undervalued). Cautious scenario $27.21, optimistic scenario $40.80. The calculation is refreshed regularly with new filings.
What is the revenue of BML, Inc. (BMLKF)?
BML, Inc. reported trailing-twelve-month revenue of about ¥151B (latest available figure, as of Nov 14, 2026).
Does BML, Inc. pay a dividend?
BML, Inc. currently shows a dividend yield of 3.19% relative to its recent price (as of Nov 14, 2026).
How much is the dividend of BML, Inc. (BMLKF) and when is the ex-dividend date?
BML, Inc. pays a dividend of $0.785 per share a year, a dividend yield of 3.2%. The next ex-dividend date is Mar 30, 2027. A dividend has been paid every year since at least 2009. The payout ratio is 60.5% of earnings. Free cash flow covers the dividend 2.26 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into BML, Inc. (BMLKF)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at BML, Inc. shrinks by 8.1 % per year for five years (discount rate 9.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 1.6 % per year. As of Nov 14, 2026.
What discount rate (WACC) does the fair value of BMLKF use?
Our models discount BML, Inc. at 9.8 %: a base by market capitalisation (small), damped by beta 0.22, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For BML, Inc. that is -8.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.8 %) and the same formula as our fair value.
How much growth has BML, Inc. (BMLKF) delivered so far?
Over the past 5 years revenue at BML, Inc. grew 1.6 % a year. The price currently implies free-cash-flow growth of -8.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of BML, Inc. (BMLKF) growing?
The median revenue growth in the sector is +4.6 % a year. That is the yardstick for the growth priced into BML, Inc. (-8.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of BML, Inc. (BMLKF)?
The free-cash-flow yield on the price is 7.20 %: that much free cash flow BML, Inc. produces per unit of market value. When it exceeds the discount rate of our models (9.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of BML, Inc. (BMLKF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For BML, Inc. it is $33.44 per share (as of Nov 14, 2026), against a price of $24.64. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is BML, Inc. stock overvalued or undervalued in 2026?
As of Nov 14, 2026, BMLKF trades below its calculated fair value: price $24.64, fair value $33.44, a gap of about +36% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BMLKF?
No. The price is what the market pays today ($24.64); the fair value is what the company's own numbers justify ($33.44). For BML, Inc. the two are $8.80 per share apart. That gap is exactly why we show both numbers side by side.
How much is BML, Inc. worth?
The market values BML, Inc. at about $923M (market capitalisation, as of Nov 14, 2026). Per share that is $24.64; our models calculate a fair value of $33.44 per share.
What do the bullish and bearish scenarios say about BMLKF?
Our models span a range for BML, Inc.: cautious scenario $27.21, base $33.44, optimistic $40.80 per share (as of Nov 14, 2026, price $24.64). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BMLKF?
BML, Inc. trades at a price-to-earnings ratio of 18.7 (as of Nov 14, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $33.44 is built from several models across several years. Median P/E at fiscal year-end, 6 fiscal years (2021 to 2026), reported earnings: 8.3. Other multiples: P/B 1.2, P/S 1.0, EV/EBITDA 4.1.
How solid is the balance sheet of BML, Inc. (BMLKF)?
Balance-sheet figures for BML, Inc. (as of Nov 14, 2026): return on equity 6.2%. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is BMLKF from its 52-week high?
BML, Inc. trades at $24.64, about 2% below its 52-week high of $25.21 and 25% above the low of $19.67 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of $33.44 is for.
Which stocks are comparable to BML, Inc.?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is BML, Inc. stock attractive at the current price?
The data as of Nov 14, 2026: price $24.64, calculated fair value $33.44 (+36%), Quality Score 70/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BMLKF calculated?
We run BML, Inc. through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $33.44 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. BML, Inc. currently trades 26% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of BML, Inc. (BMLKF)?
The closing price on Nov 12, 2026 was $24.64. Our model-based fair value is $33.44, about +36% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with BML, Inc. right now?
The price is below even our cautious bear case ($27.21). The market is more pessimistic than our downside scenario. Solid quality (70/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of BML, Inc.

How large is the market capitalisation of BML, Inc. (BMLKF)?
The market capitalisation of BML, Inc. is $923M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of BML, Inc. (BMLKF)?
The price-to-sales ratio of BML, Inc. is 0.96 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of BML, Inc. (BMLKF)?
Earnings per share at BML, Inc. are $1.32 (price ÷ EPS = P/E 18.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of BML, Inc. (BMLKF)?
The dividend yield of BML, Inc. is 3.2% (payout 59.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of BML, Inc. (BMLKF)?
The net margin of BML, Inc. is 5.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of BML, Inc. (BMLKF)?
The return on equity (ROE) of BML, Inc. is 6.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of BML, Inc. (BMLKF)?
On an EBIT basis the return on assets of BML, Inc. is 11.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of BML, Inc. (BMLKF)?
The operating margin of BML, Inc. is 7.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at BML, Inc. (BMLKF)?
Revenue at BML, Inc. is growing 2.7% versus a year earlier (3y avg −2.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at BML, Inc. (BMLKF)?
Earnings per share at BML, Inc. are growing 10.7% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch BML, Inc. in the live analysis

One click puts BML, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.